Triple Drug Combination Is Promising Option To Treat Metastatic HER2+ Breast Cancer
Thursday, May 21, 2009 - 20:35
in Health & Medicine
Combining two chemotherapy drugs with trastuzumab to treat women who have metastatic HER2+ breast cancer may offer physicians another choice in their treatment options.